stella
beta
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases — Stella
Recruiting
Back to Rheumatoid Arthritis (RA) trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(7 sites)
Netherlands
Sint Maartenskliniek Nijmegen, Nijmegen, Gelderland
Maastricht UMC+, Maastricht, Limburg
Elisabeth-TweeSteden Ziekenhuis Tilburg, Tilburg, North Brabant
Medisch Spectrum Twente, Enschede, Overijssel
Isala Zwolle, Zwolle, Overijssel
Show all 7 locations
View full record on ClinicalTrials.gov